BROSSARD, QUEBEC — (Marketwired) — 04/07/16 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces a private placement ("Private Placement") of up to $1,070,000 worth of units (each a "Unit"). Each Unit consists of:At the sole option of the holders of the Debentures, the principal amount of the
BROSSARD, QUEBEC — (Marketwired) — 02/26/16 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces termination of the private placement offering detailed in an earlier news release dated January 11, 2016.About DIAGNOSDIAGNOS is a publicly-traded Canadian corporation with a mission to improve the quality of patient
BROSSARD, QUEBEC — (Marketwired) — 01/11/16 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce its intention to complete a private placement offering ("Private Placement") of up to 30,000,000 units of the Corporation at $0.05 per unit (each a "Unit") for aggregate gross proceeds
BROSSARD, QUEBEC — (Marketwired) — 09/25/15 — DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces voting and election results from its Annual Meeting of Shareholders (the "Meeting") held on September 24, 2015.DirectorsThe four candidates proposed by Management were elected as directors of the Corporation to hold office until the closing of the ne
BROSSARD, QUEBEC — (Marketwired) — 09/23/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, provides a business update including its operating activities worldwide.Financial PositionWith the recent announcements with regards to the closing of the Corporation–s $2.29 million private placement of convertible debentures
BROSSARD, QUEBEC — (Marketwired) — 08/28/15 — DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces that the board of directors of the Corporation has approved an amendment to the Corporation–s stock option plan in order to increase the maximum number of common shares that may be issued pursuant thereto from 12,000,000 to 20,000,000 to provide long-term inc
BROSSARD, QUEBEC — (Marketwired) — 07/14/15 — This document corrects and replaces the news release that was published earlier today on the same subject.DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis and image processing, is pleased to announce new impressive results for the early automatic detection for people affected by Glaucoma.Glaucoma,
BROSSARD, QUEBEC — (Marketwired) — 07/14/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis and image processing, is pleased to announce new impressive results for the early automatic detection for people affected by Glaucoma.Glaucoma, a group of diseases that lead to optic neuropathy, is the second leading cause of blindness in the world,
BROSSARD, QUEBEC — (Marketwired) — 06/30/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces both the appointment of Lloyd M. Segal as Executive Chairman of the board of directors of the Corporation and that it has entered into an engagement agreement for a private placement ("Private Placement") co
BROSSARD, QUEBEC — (Marketwired) — 06/22/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services, including screening, software and algorithm development, data analysis, and image processing, announces today a contract for diabetic-retinopathy screening with a global pharmaceutical company and its subsidiary in Mexico. DIAGNOS will provide turn-key screening services including staff, software, equipment, and transpor